Advanced Investment Partners’s United Therapeutics UTHR Stock Holding History

Advanced Investment Partners’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$49K	Buy	+694	New	+$44.7K	0.09%	187

Other funds holding UTHR

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Advanced Investment Partners's UTHR Position: Q2 2013 in Review

Advanced Investment Partners opened a new position in United Therapeutics (UTHR) in Q2 2013: 694 shares worth $49K. The stake represents 0.09% of the portfolio and ranks #187 among its holdings.

287 funds tracked by Wall St. Rank hold UTHR as of Q2 2013.

Advanced Investment Partners held 694 shares of United Therapeutics worth $49K as of Q2 2013.
United Therapeutics was a new Advanced Investment Partners position in Q2 2013.
United Therapeutics made up 0.09% of Advanced Investment Partners's portfolio in Q2 2013, its #187 holding.
287 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2013.

Based on Advanced Investment Partners's 13F filing for Q2 2013, filed 16 Aug 2013.